1 – 10 of 27
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2024
- 
                        Mark
        Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice
    
    - Contribution to journal › Article
 
- 
                        Mark
        Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
    
    - Contribution to journal › Article
 
- 
                        Mark
        Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice
    
    - Contribution to journal › Article
 
- 
                        Mark
        ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells
    
    - Contribution to journal › Article
 
- 
                        Mark
        Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice
    
    - Contribution to journal › Article
 
- 
                        Mark
        B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
    
    - Contribution to journal › Article
 
